PharmD Info

A forum for Indian Pharmacy Professionals

List of ICH GCP Guidelines - Safety, Efficacy, Quality and Multidisciplinary Topics,
  • User avatar
#4332
Quality area include stability studies, impurities testing and Good Manufacturing Practice (GMP) risk management.

List of ICH Guidelines - Quality Topics ( Q Series)

Q10 Pharmaceutical Quality System

Q11 Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)

Q11 Q&As Questions & Answers: Selection and Justification of Starting Materials for the Manufacture of Drug Substances

Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management

Q12 IWG Training on Regulatory and Technical Considerations for Pharmaceutical Product Lifecycle Management

Q13 EWG Continuous Manufacturing of Drug Substances and Drug Products

Q1A(R2) Stability Testing of New Drug Substances and Products

Q1B Stability Testing : Photostability Testing of New Drug Substances and Products

Q1C Stability Testing for New Dosage Forms

Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products

Q1E Evaluation of Stability Data

Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV

Q2(R1) Validation of Analytical Procedures: Text and Methodology

Q2(R2)/Q14 EWG Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation

Q3A(R2) Impurities in New Drug Substances

Q3B(R2) Impurities in New Drug Products

Q3C(R6) Maintenance of the Guideline for Residual Solvents

Q3C(R7) Maintenance of the Guideline for Residual Solvents

Q3C(R8) Maintenance EWG Maintenance of the Guideline for Residual Solvents

Q3D Guideline for Elemental Impurities

Q3D training Implementation of Guideline for Elemental Impurities

Q3D(R1) Guideline for Elemental Impurities

Q3D(R2) Maintenance EWG Revision of Q3D(R1) for cutaneous and transdermal products

Q3E EWG Impurity: Assessment and Control of Extractables and Leachables for Pharmaceuticals and Biologics

Q4A Pharmacopoeial Harmonisation

Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions

Q4B Annex 1(R1) Residue on Ignition/Sulphated Ash General Chapter

Q4B Annex 10(R1) Polyacrylamide Gel Electrophoresis General Chapter

Q4B Annex 11 Capillary Electrophoresis General Chapter

Q4B Annex 12 Analytical Sieving General Chapter

Q4B Annex 13 Bulk Density and Tapped Density of Powders General Chapter

Q4B Annex 14 Bacterial Endotoxins Test General Chapter

Q4B Annex 2(R1) Test for Extractable Volume of Parenteral Preparations General Chapter

Q4B Annex 3(R1) Test for Particulate Contamination: Sub-Visible Particles General Chapter

Q4B Annex 4A(R1) Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter

Q4B Annex 4B(R1) Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-Organisms General Chapter

Q4B Annex 4C(R1) Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter

Q4B Annex 5(R1) Disintegration Test General Chapter

Q4B Annex 6 Uniformity of Dosage Units General Chapter

Q4B Annex 7(R2) Dissolution Test General Chapter

Q4B Annex 8(R1) Sterility Test General Chapter

Q4B Annex 9(R1) Tablet Friability General Chapter

Q4B FAQs Frequently Asked Question

Q5A(R1) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin

Q5A(R2) EWG Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin

Q5B Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products

Q5C Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products

Q5D Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products

Q5E Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process

Q6A Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

Q6B Specifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products

Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

Q7 Q&As Questions and Answers: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

Q8(R2) Pharmaceutical Development

Q8/9/10 Q&As (R4) Q8/Q9/Q10 - Implementation

Q9 Quality Risk Management

Q9(R1) EWG Quality Risk Management


Download all the Q Series -ICH Quality Guidelines - From Here
Similar Topics
Topics Statistics Last post
List of ICH Guidelines - Safety Topics
by Admin  - 03 Dec 2020, 09:02  - In: ICH-GCP Guidelines
0 Replies 
155 Views
by Admin
03 Dec 2020, 09:02
0 Replies 
123 Views
by Admin
03 Dec 2020, 08:44
0 Replies 
133 Views
by Admin
03 Dec 2020, 08:27
3 Replies 
3715 Views
by Admin
21 Oct 2016, 10:53
Example Pharm D V Year Project Topics - Ideas
by Varun  - 23 Nov 2020, 22:33  - In: PharmD Project
0 Replies 
757 Views
by Varun
23 Nov 2020, 22:33

Urgent hiring Regional Manager (2nd line) with Pha[…]

What is the pathway for a new vaccine introduction[…]

Vacancies for the post of Associate Professor &[…]

Data Analyst (SAS) Team Leader/Associate Manager /[…]

Join Us Today